|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.100 HKD | -0.90% |
|
+8.91% | +37.50% |
| 03/08 | Fusen Pharmaceutical Company Limited Selected in National Centralised Medicines Procurement in China | CI |
| 26/06 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| Market Cap | 70Cr 81Cr 10Cr 8.97Cr 8.37Cr 7.68Cr 14Cr 986.52Cr 15Cr 98Cr 39Cr 494.47Cr 39Cr 38Cr 1.63TCr | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 92Cr 107.13Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.3TCr 19Cr 129.41Cr 51Cr 651.39Cr 51Cr 50Cr 2.15TCr | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.90% | ||
| 1 week | +8.91% | ||
| Current month | +8.91% | ||
| 1 month | +10.00% | ||
| 3 months | -5.98% | ||
| 6 months | +48.65% | ||
| Current year | +37.50% |
| 1 week | 1.01 |  | 1.15 |
| 1 month | 1 | | 1.2 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.3 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 07/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/04/24 | Other | Chairman | 6,50,000 | 0.0867% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | +8.91% | +238.46% | -24.66% | 10Cr | |
| -0.31% | -2.29% | +22.57% | +69.33% | 4.9TCr | |
| +4.40% | +14.46% | +62.66% | +133.25% | 4.23TCr | |
| -0.89% | -0.64% | -1.48% | +15.58% | 1.24TCr | |
| +0.56% | -1.12% | +19.02% | +70.02% | 1.17TCr | |
| +0.19% | +0.77% | +31.74% | +141.01% | 911.81Cr | |
| +1.99% | +4.41% | +17.56% | +34.79% | 714.94Cr | |
| +1.82% | -0.15% | +39.41% | -13.77% | 709.32Cr | |
| +0.40% | +2.02% | +12.85% | +176.30% | 675.79Cr | |
| +6.44% | +8.26% | -24.61% | +30.64% | 595.19Cr | |
| Average | +1.37% | +3.35% | +41.82% | +63.25% | 1.52TCr | |
| Weighted average by Cap. | +1.56% | +3.75% | +30.48% | +84.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 33Cr 38Cr 4.83Cr 4.18Cr 3.9Cr 3.58Cr 6.73Cr 459.78Cr 6.84Cr 46Cr 18Cr 230.45Cr 18Cr 18Cr 761.87Cr | 27Cr 32Cr 4.05Cr 3.5Cr 3.27Cr 3Cr 5.65Cr 385.51Cr 5.74Cr 38Cr 15Cr 193.23Cr 15Cr 15Cr 638.8Cr |
| Net income | -19Cr -22Cr -2.8Cr -2.42Cr -2.26Cr -2.07Cr -3.9Cr -266.23Cr -3.96Cr -27Cr -10Cr -133.44Cr -11Cr -10Cr -441.15Cr | -1.18Cr -1.37Cr -17.46L -15.1L -14.1L -12.94L -24.34L -17Cr -24.72L -1.65Cr -64.95L -8.33Cr -65.57L -64.14L -28Cr |
| Net Debt | 37Cr 43Cr 5.44Cr 4.71Cr 4.4Cr 4.03Cr 7.58Cr 517.9Cr 7.71Cr 52Cr 20Cr 259.59Cr 20Cr 20Cr 858.18Cr | 22Cr 26Cr 3.29Cr 2.85Cr 2.66Cr 2.44Cr 4.58Cr 313.06Cr 4.66Cr 31Cr 12Cr 156.92Cr 12Cr 12Cr 518.75Cr |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | HK$1.100 | -0.90% | 19,000 |
| 06/26/06 | HK$1.110 | 0.00% | 20,000 |
| 05/26/05 | HK$1.110 | +8.82% | 1,97,000 |
| 04/26/04 | HK$1.020 | +0.99% | 47,000 |
| 03/26/03 | HK$1.010 | 0.00% | 0 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
